Clinical Trial

Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage

Study acronym: TIME-ICH
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 7, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, multicenter, randomized, quadruple-blind, placebo-controlled study. This study aims to estimate the safety and efficacy of intravenous tranexamic acid (TXA) combined with intensive blood pressure lowering in ultra-early spontaneous intracerebral hemorrhage (ICH).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-30.
Trial Details
NCT Number NCT06760078
Lead Sponsor Xuanwu Hospital, Beijing
Collaborators: Beijing Municipal Health Commission, Capital Medical University, Suzhou First People's Hospital, Linyi People's Hospital, Peking University Care Luzhong Hospital, Wuzhou Red Cross Hospital, Yantai Penglai Traditional Chinese Medicine Hospital, The First Affiliated Hospital of Hebei North University, Jiaozuo Tumor Hospital, Hunan Provincial People's Hospital, The People's Hospital of Liaoning Province, The First People's Hospital of Qujing, Yunnan Province, Huizhou Third People's Hospital, Guangzhou Medical University, Nanyang Nanshi Hospital, Xing'anmeng People's Hospital, Beijing Aerospace Center Hospital
Conditions Spontaneous Intracranial Hemorrhage, Hypertension
Enrollment 532 participants
Start Date 2024-12-31
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-07